Global Stem Cell Banking Market Research Report 2022: Market to Reach $11.5 Billion by 2026 – Adult Stem Cell Research Gains Traction, Accelerating Research Funding – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Stem Cell Banking – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Stem Cell Banking Market to Reach $11.5 Billion by 2026

The global market for Stem Cell Banking estimated at US$8.6 Billion in the year 2022, is projected to reach a revised size of US$11.5 Billion by 2026, registering a compounded annual growth rate (CAGR) of 7.6% over the period.

Researchers around the world have been focusing research activities to develop adult stem cell therapies in order to combat a variety of diseases ranging from diabetes to heart disease. Factually, adult stem cells are the only stem cells that have been approved for use in transplants for the treatment of diseases such as cancers. Adult stem cells are being used for the development of therapeutic procedures that would be useful in the treatment of cartilage defects in children; multiple sclerosis, rheumatoid arthritis and systemic lupus; restoring vision in blind patients; and in numerous cancer therapy procedures.

The United States represents the largest regional market for Stem Cell Banking, and is projected to reach US$4.3 Billion by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 10% over the period.

Rapidly rising awareness about the therapeutic capabilities of stem cells, due to the increased availability of clinical evidence, is the primary factor driving growth in the global stem cells banking market.

Rapidly rising importance of stem cells in the treatment of more than 80 diseases and growing awareness about the general populace about stem cell therapies and the importance of stem cell banking services are spurring market growth. The growing benefits of stem cells are enhancing the importance of stem cell banks. Driven by advancements in the medical research space, the life expectancy of humans has increased considerably.

However, there has been a rise in incidence of various chronic conditions, whereby focus has shifted onto the development of stem cell therapies thus paving the way for high growth in the stem cell banking market. The rising fertility rates and increase in newborns are also presenting significant opportunities due to the potential role of umbilical cord-based stem cells in treatment of various diseases. All of these are in turn necessitating extraction and preservation of stem cells, thus driving growth in the stem cells banking market.

Globally, the incidence of diseases such as cancer, cardiovascular diseases and diabetes among others continues to grow, enhancing the need for extensive and long-term treatments requiring hospitalization and involving significant costs, thus becoming a burden for healthcare systems across the world. Additional costs are often incurred due to potential of relapse in case of certain diseases.

The growing burden of diseases, high cost of treatment and the rising need for affordable treatments is presenting growth opportunities for the stem cell industry. Stem cells are currently being utilized for treatment of immune-related and blood disorders such as leukemia.

Growth in the global stem cell banking market is being driven by the rapid pace of advancements being witnessed in the regenerative medicine space. As the medical sector focuses on developing artificial tissues capable of integrating with the human body, there is significant focus on medical analysis and testing in research institutes and biological labs. This in turn raises the importance of developing stem cell samples and creating repositories capable of storing stem cell samples for research purposes.

North America and Europe are leading the global stem cell banking market. In the US, rising healthcare costs and increasing need for superior treatment of conditions affecting the aged are emerging as favorable trends driving the growth in the stem cells banking market.

Many have begun to see stem cell based therapies as a viable option for tackling the increasing healthcare costs in the country and as a source for addressing unmet needs in the area of medicine. The presence of a large and expanding network of stem cell banks in the region, increase in approvals for stem cells in the treatment of various diseases, and advancements in technologies for collecting and preserving stem cells are favoring growth.

Rising investments in stem cell research projects by pharmaceutical and biopharmaceutical companies and increase in stem cell transplants procedures being performed are also sustaining growth in the region. In Europe, the rising prevalence of chronic illnesses such as cancer, growing demand for personalized treatments and medicines, increased focus on R&D related to stem cell applications, and establishment of high-tech stem cell research labs are all contributing to the growth of stem cell banking market in the region. Aging population is likely to emerge as a significant driver of future growth in the European stem cell banking market.

Emerging markets across Asia Pacific, Latin America, and Middle East & Africa are poised to offer significant potential for growth of stem cell banks, due to the rapid growth of healthcare services in the regions and the vast patient population. Growing investments being made by regional governments especially in China and India to enhance healthcare services will also drive opportunities for the stem cell banking market.

What’s New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies – Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to a digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Stem Cells, Application Areas, and the Different Types – A Prelude
• Applications of Stem Cells
• Types of Stem Cells
• Cord Blood
• Umbilical Cord Tissue
• Bone Marrow Stem Cells
• Adipose-Derived Stem Cells (ADSCs)
• Human Embryo-Derived Stem Cells (HESCS)
• Global Stem Cell Banking Market Poised for a Rapid Growth
• Developed Regions Lead, Emerging Economies to Spearhead Future Growth
• List of Family Cord Blood Banks in the US
• Placental and Cord Blood Banks Dominate the Cord Blood Banking Market
• Global Number of Annual Newborns and Private Cord Blood Banks
• Global Select Leading Cord Blood Banks Based on Inventory
• A Peek into China’s Cord Blood Banking Industry
• Evolving Landscape of Cord Blood Banking Industry
• Placental Stem Cells and Potential Clinical Applications
• Changing Business Models for Stem Cell Banking
• Stem Cell Banking – Global Key Competitors Percentage Market Share in 2022 (E)

2. FOCUS ON SELECT PLAYERS (Total 78 Featured)

• Cord Blood Registry
• CordLife Group Ltd.
• Cryo-Cell International, Inc.
• Cryo-Save AG
• Global Cord Blood Corporation
• LifeCell International Pvt., Ltd.
• Smart Cells International Ltd.
• StemCyte Inc.
• ViaCord
• Vita 34 AG

3. MARKET TRENDS & DRIVERS

• Increasing Investments in Stem Cell-Based Research Widen Prospects for Stem Cell Banking Market
• Stem Cell Research Policies Impact Funding Volumes
• Adult Stem Cell Research Gains Traction, Accelerating Research Funding
• Adult Stem Cells Vs. Embryonic Stem Cells: A Comparison
• Embryonic Stem Cell Research Bogged Down by Ethical Issues & Technical Hurdles
• Induced Pluripotent Stem Cell (iPSC) Research: The Latest Vertical
• Sustained Emphasis on Mesenchymal Stem Cell Research
• Emergence of Advanced Technologies for Stem Cell Preservation, Storage and Processing Augurs Well for Market Growth
• Growing Incidence of Major Diseases to Boost the Demand for Stem Cells, Driving Stem Cell Banking
• Ageing Demographics to Drive Demand for Stem Cell Banking
• Global Aging Population Statistics – Opportunity Indicators
• Bone Marrow Stem Cells Market on a Rapid Growth Path, Spurring the Need for Stem Cell Banking
• Development of Regenerative Medicine Accelerates Demand for Mesenchymal Stem Cell Banking
• Rise in Volume of Orthopedic Procedures Boosts Prospects for Stem Cell Banking
• Increasing Demand for Stem Cell Based Bone Grafts: Promising Growth Ahead for Stem Cell Banking
• Rise in the Number of Hematopoietic Stem Cell Transplantation Procedures Propels Market Expansion
• Hematopoietic Stem Cell Storage
• Dental Mesenchymal Stem Cells: An Evolving Niche
• Therapeutic Potential of Dental Pulp Stem Cells (DPSCs) in Various Diseases
• High Operational Costs of Stem Cell Banking – A Key Market Restraint

4. GLOBAL MARKET PERSPECTIVE

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/egrumf

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900